Anders Hammarberg

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness
    Glenn Lawyer
    Department of Psychiatry, University of Oslo, Norway
    BMC Pharmacol 10:5. 2010
  2. ncbi The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial
    Anders Hammarberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska University Hospital, M4 02SE 17176, Stockholm, Sweden
    Psychopharmacology (Berl) 205:53-62. 2009
  3. ncbi The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin
    Anders Hammarberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Sweden
    Brain Res 1305:S2-6. 2009
  4. ncbi Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers
    Anders Hammarberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Ther Drug Monit 32:489-96. 2010
  5. ncbi Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial
    Nitya Jayaram-Lindström
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Am J Psychiatry 165:1442-8. 2008
  6. ncbi Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence
    Nitya Jayaram-Lindström
    Department of Clinical Neuroscience, Section for Alcohol and Drug Dependence Research, Karolinska Institutet, Stockholm, Sweden
    Neuropsychopharmacology 33:1856-63. 2008
  7. ncbi Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo
    Helen Dahl
    Alcohol Laboratory, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
    Alcohol Alcohol 46:553-7. 2011
  8. ncbi A comparison of two intensities of psychosocial intervention for alcohol dependent patients treated with acamprosate
    Anders Hammarberg
    Department of Clinical Neuroscience, Alcohol and Drug Dependence Research, Karolinska Institutet, Stockholm
    Alcohol Alcohol 39:251-5. 2004
  9. ncbi MR volumetry during acute alcohol withdrawal and abstinence: a descriptive study
    Ingrid Agartz
    Karolinska Institutet, Department of Clinical Neuroscience, Clinical Alcohol and Drug Addiction Research Section and Human Brain Informatics, Psychiatry Section, Karolinska Hospital, Stockholm SE-171 76, Sweden
    Alcohol Alcohol 38:71-8. 2003

Detail Information

Publications9

  1. ncbi Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness
    Glenn Lawyer
    Department of Psychiatry, University of Oslo, Norway
    BMC Pharmacol 10:5. 2010
    ..In addition to contrasting patients with controls, a number of analyses sought to identify possible confounding effects from alcohol...
  2. ncbi The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial
    Anders Hammarberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska University Hospital, M4 02SE 17176, Stockholm, Sweden
    Psychopharmacology (Berl) 205:53-62. 2009
    ..Acamprosate is a widely utilized, efficacious treatment for relapse prevention in alcohol-dependent patients; yet, little is known regarding its therapeutic mechanism of action...
  3. ncbi The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin
    Anders Hammarberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Sweden
    Brain Res 1305:S2-6. 2009
    ..Further, a significant correlation was shown between craving and alcohol consumption during study. No changes in hormonal levels were found in acamprosate treated patients compared to placebo...
  4. ncbi Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers
    Anders Hammarberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Ther Drug Monit 32:489-96. 2010
    ..Furthermore, the results suggest that the mechanism of action of acamprosate needs to be further explored with regard to the peripheral actions of the drug...
  5. ncbi Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial
    Nitya Jayaram-Lindström
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Am J Psychiatry 165:1442-8. 2008
    ..The aim of this study was to investigate the efficacy of naltrexone in comparison with placebo in reducing relapse to amphetamine use in amphetamine-dependent patients...
  6. ncbi Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence
    Nitya Jayaram-Lindström
    Department of Clinical Neuroscience, Section for Alcohol and Drug Dependence Research, Karolinska Institutet, Stockholm, Sweden
    Neuropsychopharmacology 33:1856-63. 2008
    ..The results suggest that the subjective effects of amphetamine could be modulated via the endogenous opioid system. The potential of naltrexone as an adjunct pharmaceutical for amphetamine dependence is promising...
  7. ncbi Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo
    Helen Dahl
    Alcohol Laboratory, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
    Alcohol Alcohol 46:553-7. 2011
    ..This study compared urinary EtG and EtS measurement with self-reports for detection of prior drinking in alcohol-dependent outpatients treated with the anti-craving medication acamprosate or placebo...
  8. ncbi A comparison of two intensities of psychosocial intervention for alcohol dependent patients treated with acamprosate
    Anders Hammarberg
    Department of Clinical Neuroscience, Alcohol and Drug Dependence Research, Karolinska Institutet, Stockholm
    Alcohol Alcohol 39:251-5. 2004
    ..To compare two levels of psychosocial intervention in combination with acamprosate medication for the treatment of alcohol dependence...
  9. ncbi MR volumetry during acute alcohol withdrawal and abstinence: a descriptive study
    Ingrid Agartz
    Karolinska Institutet, Department of Clinical Neuroscience, Clinical Alcohol and Drug Addiction Research Section and Human Brain Informatics, Psychiatry Section, Karolinska Hospital, Stockholm SE-171 76, Sweden
    Alcohol Alcohol 38:71-8. 2003
    ..The time limit of WM volume restitution is variable and continues longer than 3 weeks after withdrawal...